StemCells (STEM) Posts Q3 Loss of $0.31, Sales Top Expectations
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/15/2026
- S&P 500, Nasdaq pare declines as AI rout teeters; healthcare, staples gain
- U.S. producer prices rise by 1.3% month-on-month in September
- Brent steady as US weighs easing sanctions on global 'shadow fleet'
- UBS now expects a third Fed rate hike after hot September inflation print
- Tesla-SpaceX Merger could be announced before December, Barclays says
Tweet
Share
E-mailGet Alerts STEM Hot Sheet
Price: $3.59 --0%
Revenue Growth %: +5.6%
Financial Fact:
Interest expense: -128
Today's EPS Names:
NTRP, FMCB, LOOP, More
Revenue Growth %: +5.6%
Financial Fact:
Interest expense: -128
Today's EPS Names:
NTRP, FMCB, LOOP, More
Join SI Premium – FREE
StemCells (NASDAQ: STEM) reported Q3 EPS of ($0.31), $0.14 better than the analyst estimate of ($0.45). Revenue for the quarter came in at $224 thousand versus the consensus estimate of $210 thousand.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Stem Inc. (STEM) PT Lowered to $4.50 at Susquehanna
- State Street (STT) Tops Q3 EPS by 2c
- Charles Schwab (SCHW) Tops Q3 EPS by 3c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
